BRC News

We're taking a short break from posting on our website until after the election to comply with government general election guidance.

BRC Operations Manager Dr Louise English reflects on the success of the second BRC Lates event in this blog.

Collaborative research projects across the three UCL-linked BRCs which are applying artificial intelligence (AI) to complex problems in cancer, sepsis, hearing loss, neuromuscular diseases and emergency medicine will receive combined funding from the three BRCs to accelerate their progress.

People exposed to a lifetime of psychosocial adversity may have an impaired ability to produce the dopamine levels needed for coping with acutely stressful situations, according to a UCL-led study.

77-year-old Bridget Barker from Hackney had successful robotic surgery to treat her lung cancer in August 2019. The cancer was discovered during a lung health check following an invitation from her GP, which was sent to her as part of the SUMMIT study.

Mouth cancer patients who have their neck glands removed at the same time as having the cancer removed from their mouth have a lower risk of death and tumour recurrence according to a study involving UCLH.

A drug company has announced positive results in the first global trial of a drug for a rare neuromuscular disease Friedreich’s ataxia (FA) which included patients from UCLH.

UCLH and UCL will benefit from a £56 million Cancer Research UK (CRUK) investment in next-generation radiotherapy research.

Alison Finch, an Assistant Chief Nurse at UCLH, features in a National Institute for Health Research (NIHR) video this week to encourage healthcare professionals to get involved in research.

Attendees at the inaugural – and sold out – ‘BRC Lates’ event run in collaboration with UCL Special Collections were treated to talks from UCL researchers around the theme of medical imaging and explored rare books, archives and manuscripts from UCL’s unique collection.

Researchers at UCL Queen Square Institute of Neurology (IoN) and the UCLH National Hospital for Neurology & Neurosurgery (NHNN) are set to test whether a drug can slow progression of the devastating neurodegenerative condition Multiple System Atrophy (MSA).

UCL has received a £1 million grant from the British Heart Foundation (BHF) to develop a new team of scientists to apply advances in computer science and big data to tackle cardiovascular disease.

NHS patients who have taken part in clinical trials have expressed their gratitude to researchers in a film celebrating the work of the National Institute for Health Research (NIHR) Biomedical Research Centres (BRCs) to mark the retirement of outgoing Chief Medical Officer Professor Dame Sally Davies.

Researchers have identified 44 genes linked to age-related hearing loss, giving a much clearer understanding of how the condition develops, according to a new study led by UCL and King’s College London.

Researchers and clinicians at UCLH and UCL have been highlighted in the Evening Standard’s list of the most influential people in London.